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INTRODUCTION 
 Multi - organ  dysfunction  syndrome (MODS) is the leading cause of  
morbidity and mortality for patients admitted with sepsis, and develops in 
about  15% of  all admissions. Over the past years many scoring models have 
been developed to describe the severity of illness in patient admitted with 
sepsis. As an example, the first Sepsis-related Organ Failure Assessment score, 
later called the Sequential Organ Failure Assessment (SOFA) score, was 
introduced in 1994(1).The aim was to quantify the severity of the patient’s  
illness based on the degree of organ  dysfunction, serially over time. Although 
severity of illness scoring systems such as the Acute Physiology and Chronic 
Health Evaluation (APACHE) II  and the Simplified Acute Physiology Score 
(SAPS) II  are based on the first 24hrs of admission, the SOFA scoring system 
takes into account the time course  of a patient's condition during the entire stay 
in the hospital . This enables surgeons to follow the evolving disease process. 
The Sequential Organ Failure Assessment (SOFA) score is a simple and 
objective score that allows for calculation of both the number and the severity 
of organ dysfunction in six organ systems. It is a six-organ dysfunction score 
measuring multiple organ failure daily. Each organ is graded from 0 (normal) 
to 4 (the most abnormal). 
 Although SOFA was developed primarily to describe and quantify organ 
function, it has been demonstrated in several studies to predict mortality and  
morbidity of critically ill patients. Early prediction of outcome in surgical 
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sepsis is very likely to aid suitable modification of management strategies (2). 
This may improve prognosis in such patients and prevent mortality to some 
extent. This scoring system also guides the efficient utilization of hospital 
resources, especially in a resource starved setting. This helps in preventing 
dumping of valuable drugs and treatment modalities in a patient, who may not 
survive in spite of all efforts. On the contrary they can be utilized for a person, 
who may improve well with such costly intervention. Also, the score can be a 
useful in clinical research tool to evaluate various therapeutic interventions in 
early sepsis. 
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AIMS AND OBJECTIVES 
1. To assess the incidence and severity of organ dysfunction in patients with 
sepsis  in surgical unit  
2. To predict the outcome among them  
 
 
 
 
 
 
 
  
 
 
15 
 
REVIEW OF LITERATURE 
HISTORY 
The word sepsis was first coined by Hippocrates (460-370bc) and it is 
derived  from greek word . 
 
 
 
    
 
Figure 1 Ignaz Semmelweis 
Ignaz Semmelweis (1818-1865) was the first researcher who developed 
on modern aspects of sepsis (43). He was an obstetrician at the Vienna General 
Hospital, during that time when the death of women in childbed from puerperal  
fever was a common complication. He found that there was highest mortality in 
his department of around 18%. Semmelweis discovered that it was common for 
medical students to examine pregnant women directly after conducting post 
mortem. Hygenic measures such as hand washing or surgical gloves were not 
practiced in those times. Semmelweis detected that childbed fever was caused 
by "decomposed animal matter that entered the blood system”(4). As a matter of 
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fact, he lowered the mortality rate to 2.55% by introducing hand washing using 
chlorinated lime solution before any gynaecological procedures.  
However, these hygienic measures were not accepted and his colleagues 
harassed him and made him to leave the city .In 1863, after around 15yrs of his 
findings, his work was published as "Aetiology, terminus and prophylaxis of  
puerperal fever" (Die Aetiologie, der Begriff und die Prophylaxis des  
Kindbettfiebers)(42). Semmelweis later died from wound infection. It is an irony 
of fate that he died from the same disease that he detected.  
William Osler, was considered as father of American medicine,  made 
his observations in treatise The Evolution of Modern Medicine:  “Except on 
few occasions, the patient appears to die from the body's response to  infection 
rather than from it.”(5) 
 
 
 
 
 
 
Figure 2: William Osler 
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 From 1878 - 1880, Robert Koch, (41) District Medical Officer for Wollstein. 
He developed the following four postulates to identify the ssociation  between 
organisms with specific diseases: 
1. The microorganism or other pathogen must be present in all cases of the  
disease. 
2. The pathogen can be isolated from the diseased host and grown in pure 
culture.                               
3. The pathogen from the pure culture must cause the disease when  
inoculated into a healthy, susceptible laboratory animal. 
4. The pathogen must be re-isolated from the new host and shown to be the 
same as the originally inoculated pathogen. 
 
 
 
 
 
 
Figure 3: Robert Koch 
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The French chemist Louis Pasteur (1822-1895) discovered that a single 
cell organisms caused putrefaction. He found that as microbes and these are 
responsible for causing the disease.(6) He also found that the bacteria can be 
killed by heating at specific temperature.  
 This meant that a fluid could be sterilised. He was able to elucidate the 
principle that contagious diseases are caused by specific microbes and that 
these microbes are foreign to the infected organism.  
DEFINITIONS 
 In 1992, Bone and colleagues convened a consensus conference on the 
problem of organ damage caused by excessive activation of the endogenous 
inflammatory response. They defined four sepsis-related clinical syndromes.  
These four syndromes were defined in pathophysiologic terms as a hierarchy 
corresponding to four steps of increasingly exaggerated inflammatory  
responses- SIRS, sepsis, severe sepsis and septic shock.(40) The first category of 
SIRS is caused by inflammatory mediators released by lymphocytes, 
macrophages, granulocytes, and vascular endothelial cells. These activated 
immune cells release cytokines, enzymes, and oxygen radicals that are 
beneficial because they can destroy invading microorganisms. These immune 
mediators also initiate coagulation pathway, amplify the release of additional 
cytokines and vasoactive agents, and increase capillary membrane 
permeability. 
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Infection is defined as presence of microorganism in the body tissue or 
in blood stream associated with inflammatory response to that organism . At 
the site of infection the classic findings of rubor, calor, and dolor in areas like 
the skin or subcutaneous tissue are common. 
SIRS Criteria is as follows: 
  Heart rate ≥ 90 beats/min 
 Respiratory rate ≥20/min OR PaCo2<32mmHg 
 Temperature ≥38°C (100.4oF) or ≤36°C (96.8oF 
 WBC total count ≥12,000/mL or ≤4,000/mL  
SIRS can be caused by a variety of disease processes, including 
pancreatitis, polytrauma, malignancy, and transfusion reaction, and infection. 
SIRS caused by infection is termed sepsis, and is mediated by the production of 
a cascade of pro-inflammatory mediators produced by exposure to microbial 
products. 
Septic shock is a medical condition as a result of 
severe infection and sepsis, though the microbe may be systemic or localized to 
a particular site. It can cause multiple organ dysfunction syndrome (formerly 
known as multiple organ failure) and death(39). Its most common victims are 
children, immuno-compromised individuals, and the elderly, as their immune 
system cannot deal with infection as effectively as those of healthy adults.  
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 Frequently, patients suffering from septic shock are cared for in 
intensive care  unit. The mortality rate from septic shock is approximately 25–
50%.(38) Septic shock is defined as stage of SIRS (Systemic inflammatory 
response  syndrome), in which sepsis, severe sepsis and multi organ 
dysfunction were  considered as different stages of its patho-physiological 
process.  
PATHOPHYSIOLOGY 
 The pathophysiology of shock in sepsis is multidimensional and 
complex because of the interaction of multiple physiologic and inflammatory 
events (Fig 4). The majority of patients with septic shock have hypotension 
associated with arterial vasodilation. A minority of patients in septic shock are 
hypovolemic as a result of inflammatory edema or fluid loss and they have a 
hemodynamic pattern of marked vasoconstriction and low-flow shock. 
Typically, patients in vasodilatory septic shock have cardiac output 2 fold or 
greater than normal associated with mean arterial pressure less than 65 mm Hg. 
The reduction in systemic vascular resistance (SVR)in these patients is 
attributed to vasodilation in organs with high capillary density, like  skin and 
skeletal muscle.(7) 
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Figure 4: Initiation Of Inflammatory Response 
 Experimental evidence indicates that excessive production of nitric 
oxide, a potent vasodilator, is a primary mechanism for the reduced SVR in 
patients with septic shock. Because of the induction of a potent enzyme system, 
patients with severe sepsis and septic shock produce large amounts of nitric 
oxide, and elevated generation of  nitric oxide near vascular smooth muscle 
overwhelm the vasoconstrictive effects of the endogenous vasoconstricting 
hormones (α-adrenergic catecholamine, angiotensin II, and vasopressin)(44). In  
clinical trials, treatment of patients in vasodilatory shock with inhibitors of 
nitric oxide synthesis did not improve their outcome(37). Further research is 
needed to identify treatments that effectively modify the adverse influence of 
nitric oxide in septic shock.(45) 
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Figure 5 : Pathway Showing Inflammatory Response 
MULTI ORGAN DYSFUNCTION SYNDROME 
 The abnormal function or failure of more than one organ or organ 
system requiring medical support to maintain homeostasis is called MODS(8). 
In a susceptible individual, under the influence of associated co-morbidities, 
the organ systems fail one by one ultimately leading to a complicated disease 
process and death.    
Pathogenesis: The general principles governing the syndrome of multiorgan 
dysfunction are,(46) 
1) Organ failure, no matter how defined, must persist beyond 24 hours 
2) Mortality risk increases as the patients accrue additional failing 
3) Prognosis is worsened by increased duration of organ failure. 
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 These observations remain true across various critical care settings all 
over the world. Systemic inflammatory response syndrome (SIRS) is the 
common basis for multi organ system failure. Infection is by far the commonest 
cause of SIRS. Though other triggers like pancreatitis, trauma and burns etc 
can also elicit a similar response. 
MANAGEMENT OF SEPTIC SHOCK(33) 
Treatment of septic shock consists of following methods  
 Volume resuscitation 
 Early antibiotic administration 
 Early goal directed therapy 
 Rapid source identification and control. 
 Support of major organ dysfunction. 
 Sequestration of  lipopolysaccharides. 
Treatment guidelines call for the administration of broad-spectrum antibiotics 
within the first hour following recognition of septic shock. Prompt  antibiotics 
is critically important, as risk of dying increases by approximately 10% for 
every hour of delay in receiving antibiotics(32). Time constraints do not allow 
the culture, identification and testing for antibiotic sensitivity of the specific 
microorganism responsible for infection. Therefore, combination antimicrobial 
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therapy, which covers a wide range of potential causative organisms, is tied to 
better outcomes.  
 Because lowered blood pressure, in septic shock contributes to poor 
perfusion, fluid resuscitation is an initial treatment to increase blood 
volume. Crystalloids such as normal saline and lactated Ringer's solution are 
recommended as the initial fluid of choice(9), while the use of colloid solutions 
such as hydroxyethyl starch have not shown any advantage or decrease in 
mortality. When large quantities of fluids are given, administering albumin has 
shown some benefit.  
 Among the choices for vasopressors, norepinephrine is superior 
to dopamine in septic shock. Norepinephrine is the preferred vasopressor, while 
epinephrine can be added to norepinephrine when needed. Low 
dose vasopressin may also be used as an addition to norepinephrine, but is not 
recommended as a first-line treatment. Dopamine can cause rapid heart 
rate and arrhythmias, and is only recommended in combination with 
norepinephrine in those with slow heart rate and low risk of arrhythmia(31). In 
the initial treatment of hypotension in septic shock, the goal of vasopressor 
treatment is a mean arterial pressure (MAP) of 65mm Hg.(47) 
 Antimediator agents may be of some limited use in severe clinical 
situations however are controversial:  
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 Low dose steroids (hydrocortisone) for 5 – 7 days led to improved 
outcomes.  
 Recombinant activated protein C (drotrecogin alpha) in a 2011 concrane   
review was found not to decrease mortality and thus was not recommended 
for use.  Other reviews however comment that it may be effective in those 
with very severe disease. The first and only activated protein C drug, 
drotrecogin  alfa (Xigris)(10), was voluntarily withdrawn in October 2011 
after it failed to show a benefit in patients with septic shock, including the 
more severe disease . 
Figure 6 : Management of Septic Shock 
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SCORING SYSTEMS 
 Typically, scoring systems are used to quantify the severity of illness of 
a study population, to compare different populations by summarizing the cases, 
and more recently, as an entry criteria for certain interventional studies. They 
are also used to compare actual versus expected outcomes for a specific 
physician, ICU, hospital, or region (30). Although these systems can be applied 
to individual patients to predict outcome, that practice is controversial. 
Previous investigators have identified a link between the number of 
dysfunctional organs and both short-term and long-term mortality among 
emergency department patients with infection. A few of the most commonly 
used such scoring systems are  
 APACHE  
 SOFA  
 Simplified acute physiology score (SAPS) 
 Mortality probability model (MPM) 
 Therapeutic intervention scoring system (TISS) 
 Logistic organ dysfunction score (LODS) 
 Multiorgan dysfunction score (MODS) 
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APACHE SCORING SYSTEM (48) 
  Knaus et al developed APACHE scoring system in 1985. It consists of 
12 physiological variables calculated by multivariate analysis. The scores 
ranges from 0 – 71. The data of APACHE II are calculated using the 
equation(11). 
 In Hospital Mortality . 
(R/1-R) = -3.517 + (APACHE   × 0.146 + S + D) 
R = Risk of death in hospital, S = Risk due to emergency surgery, and D = Risk 
due to any specific disease.  
A score of 25 or less denotes less than 50% mortality and score of 35 or 
more denotes more than 85% mortality. Although APACHE II score provides 
severity of illness of particular group of patients, they provide little information 
about the risk of individual patients. As an improvised version of APACHE II, 
APACHE III and IV were designed for better prediction.(29) 
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Figure 7 : APACHE Scoring System 
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SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) 
Simplified acute physiology score was introduced by Le Gall et al in 
1984(28). It was designed to encounter the difficulties faced during assessment 
of APS used in APACHE score. It was calculated by taking the 13 most easily 
measurable physiological variables used in APACHE score. The total score is 
obtained as the highest score of ICU admission in the first 24 hours. SAPS had 
its advantage over APACHE II in accurately predicting mortality in a stratified 
group of patients.(12) 
Figure 8 : SAPS Scoring System 
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MORTALITY PROBABILITY MODEL 
Lemeshow et al in 1985, first published the mortality prediction 
model(49). He designed 4 models, like probability of death from data collected 
at ICU admission (MPM0), Probability of death based on 24 hours 
data(MPM24)probability of death based on 48 hours data(MPM48), probability 
of death over a period of time based on MPM0 and change in probability 
between MPM0 and MPM24 and change in probability between MPM24 and 
MPM48. Lemeshow et al also developed MPM II to assess serial changes in 
ICU patients over 72 hours of ICU stay(13). Hence this model had a better 
advantage over APACHE and SAPS since these two models lack ability of 
serial assessment.  
Figure 9: Mortality Probablity Models 
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THERAPEUTIC INTERVENTION SCORING SYSTEM 
 Cullen et al in 1974 developed this scoring system(14). It utilises 76 
monitoring and therapeutic parameters. Scores of the first three day ICU stay 
correlate well with survival. So it is useful in discriminating survivors and non 
survivors, according to whether the score increases or decreases, 
respectively.(50) 
 
 
 
 
 
 
 
 
 
Figure 10: Therapeutic Intervention Scoring System 
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SOFA SCORING SYSTEM 
 The SOFA score was developed in 1994, by the European Society of 
Intensive Care and Emergency Medicine, to provide a means to describe the 
degree of organ failure in individuals and groups of ICU patients. Vincent et al 
published the SOFA score and proved that infected patients had more risk of 
organ dysfunction than the non- infected .(15) 
 
Figure 11 : SOFA Scoring System 
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SOFA scoring system analyses 6 variables namely (16) 
 Pao2/Fio2 ratio(for respiration) 
 Platelets(for coagulation) 
 Bilirubin (for liver function) 
 Creatinine (for renal function) 
 Glasgow coma scale(to assess level of consciousness) 
 Blood pressure and the need for inotropic support.  
A score of 0 to 4 is given for each of these six variables and a score is 
obtained using sum total value of each of these parameters. The worst values 
on each day are recorded and organ function total score can thus be monitored 
over time. 
The increasing SOFA score and the mean SOFA score are highly useful 
in assessing prognosis and risk stratification of patients. 
PARAMETERS 
PAO2/FIO2 RATIO: 
It is simply defined as the amount of inspired oxygen that reaches the 
blood. It is impaired in case of lung injury due to any cause. It is also called 
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carrico index(27). According to AECC criteria, acute respiratory distress 
syndrome is diagnosed , if Pao2/Fio2 ratio is less than or equal to 200.(17) 
 Pao2 is the partial pressure of oxygen in the arterial blood. It is 
measured in millimetres of mercury (mmHg) or torr units. It is measured by an 
arterial blood gas analyser(ABG). Normal Pao2 is 75 – 100mmHg. 
 Fio2 is the percentage of oxygen in the inspired mixture of air. Normal 
Fio2 in inspired atmospheric air is 0.21(21%). In a mechanical ventilator it is 
usually set as 30 – 40%. In a mechanically ventilated patient 100% oxygen is 
not administered due to high risk of oxygen toxicity. 
 Kerbing and his co workers assessed the clinical relevance of variation 
in Pao2/Fio2 ratio. They demonstrated the clinical utility of this parameter. 
The Pao2/Fio2  scores are 
 Score 0 – more than  400 
 Score 1 – less than or equal to 400 
 Score 2 – less than or equal to 300 
 Score 3 – less than or equal to 200 
 Score 4 – less than or equal to 100.                   
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Figure 12 : Arterial blood gas analyser (ABG) 
CREATININE 
 In SOFA scoring serum creatinine values are estimated periodically to 
assess the renal function over a period of time till the patient is in icu. 
Creatinine is a breakdown product of creatine phosphate, which is found in 
muscle. Each day 1-2 % of muscle creatine is converted to creatinine. It  is 
excreted both by glomerular filtration and tubular secretion. Rise in serum 
creatinine is a marker of damage to nephrons. Normal serum values are 0.7 – 
1.2(males) and 0.5 – 1.0(females) (18). Impaired renal function can be due to pre 
renal, renal or post renal causes. Some of the commonest causes of renal failure 
are 
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 Severe dehydration 
 Acute pyelonephritis 
 Diabetes  
 Hypertension 
 Renal calculi 
 Hemorrhagic fevers 
 Disseminated intravascular coagulation 
 Autoimmune and other connective tissue disorders. 
The scores used for creatinine in SOFA score are,(19) 
 Score 0 – less than 1.2 mg/dl 
 Score 1 – 1.2 to 1.9 mg/dl 
 Score 2 – 2.0 to 3.4 mg/dl 
 Score 3 – 3.5 to 4.9 mg/dl 
 Score 4 – more than 5 mg/dl 
  
 
 
37 
 
PLATELET COUNT 
 Platelet count is used as a parameter in SOFA score to assess 
coagulation function and its impairment during disease states. The coagulation 
mechanism involves activation, adhesion and aggregation of platelets in 
response to a stimuli, say an injury or infection. Both platelet number and 
function should be adequate for this function to be intact. Coagulation cascade 
is one of the best understood system in humans. Primary hemostasis is mainly 
due to platelets, which is characterised by formation of platelet plugs. 
Activated platelets release stored granules into the blood. These granules 
contain 
 Serotonin 
 ADP 
 Platelet activating factor 
 Platelet factor 4 
 Vonwillebrand factor 
 Thromboxane A2 
 All these substances when released into the blood stream activate 
additional platelets. These steps lead on to the activation of various enzymes of 
coagulation cascade resulting in activation of clotting factors, which is called 
secondary hemostasis. Various systemic illness can be associated with a 
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decreased platelet count. It can be either due to decreased production, increased 
destruction or impairment of platelet function.   
Causes of  thrombocytopenia (20) 
 Vitamin B12 and folate deficiencies 
 Infections like HIV disease 
 Leukemias 
 Disseminated intravascular coagulation 
 Thrombotic thrombocytopenic purpura 
 Viral infections 
 Gram negative septicaemia 
 Heparin induced thrombocytopenia 
 Radiation induced bone marrow suppression 
 Drug toxicity 
The scores used for platelet count in SOFA are 
 Score 0 - >150 × 103/mm3 
 Score 1 - <150× 103/mm3 
 Score 2 - <100× 103/mm3 
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 Score 3 - <50× 103/mm3 
 Score 4 - <20× 103/mm3 
BILIRUBIN 
` Bilirubin levels are measured as a marker of liver function. Liver plays a 
pivotal role in regulating a large number of metabolic pathways in the body. 
Bile is secreted in the hepatic lobules and it drains ultimately into the bile duct 
after traversing through canaliculi, small bile ducts and larger bile ducts. 
It consists of bile acids, phospholipids and unesterified cholesterol. 
Daily bile output from the liver is 500 – 600ml. It consists of two fractions. 
Direct or hydrophilic type and indirect or hydrophobic type. Conjugation of 
indirect to direct fraction takes place in the liver, which is an enzyme mediated 
process. This whole array of steps in the formation to elimination of bile can be 
disturbed in disease states. Elevations in bilirubin levels can be used to assess 
liver function over time(21), which helps in predicting worsening or 
improvement of liver function in a patient with sepsis. 
Some of the conditions in which bilirubin levels are raised are, 
 Acute hepatitis 
 Alcoholic liver disease 
 DIC and septicaemia 
 Hepatocellular carcinoma 
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 Haemolytic jaundice                          
 Obstructive jaundice 
 Congenital liver enzyme abnormalities 
 Massive blood transfusion  
 Most biologic system in the body gets affected by excess bilirubin in 
blood. Normal bilirubin levels in blood are 1.0 to 1.5mg/dl. Upto 30% of that is 
direct or conjugated bilirubin, which equals 0.3 mg/dl. It is water soluble. The 
rest of the fraction is insoluble in water and it is called unconjugated bilirubin. 
This is the toxic form of bilirubin, which when accumulates in excess gets 
deposited in the brain especially in the basal ganglia which may lead to 
seizures or neurological deficits.  
The scores used for bilirubin are 
 Score 0 - < 1.2 mg/dl 
 Score 1 – 1.2 to 1.9 mg/dl 
 Score 2 – 2.0 to 5.9 mg/dl 
 Score 3 – 6.0 to 11.9 mg/dl 
 Score  4 - >12 mg/dl 
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GLASGOW COMA SCALE 
It gives a reliable and objective way of  recording the conscious state of 
a  person. It is easy to use both for the medical and paramedical personnel for  
initial as well as continuing medical assessment in an ICU(22). It has value in  
predicting ultimate outcome. Three types of responses are assessed. 
GCS scale was used initially only for head injury patients. Now it is 
being used  both for acute medical and trauma patients. It is also being used to 
monitor  patients in ICU in a seriously ill state. The scale was published in 
1974 by Graham Teasdale and Bryan J. Jennett, at the University of Glasgow 
Institute Of  Neurological Sciences. Both of them were neurosurgeons.(23) 
Figure 13 : Glasgow Coma Scale 
 
 
42 
 
The highest possible score is 15, that is in a fully awake person. The 
lowest possible score is 3, which means deep coma or death.  
The scores used for GCS in SOFA are 
 Score 0 – 15 
 Score 1 – 13 to 14 
 Score 2 – 10 to 12 
 Score 3 – 6 to 9 
 Score 4 - <6 
BLOOD PRESSURE 
 “There is no doubt that proper functioning of our pipes and pumps does 
have an immediate urgency well beyond that of almost any of our other bits 
and pieces”. (24) 
Steven vogel (vital circuits, 1992) 
 Hypotension and shock may occur as a final consequence of any organ 
dysfunction. Maintaining an adequate blood pressure is essential for perfusion 
and oxygenation of vital organs. In short, shock is a clinical syndrome resulting 
from inadequate tissue perfusion of any cause, resulting in an imbalance 
between the requirement and supply of oxygen, causing cellular dysfunction. 
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This goes on and on like a vicious cycle resulting in cellular death and multi 
organ dysfunction. 
Classification of shock (25) 
Hypovolemic Septic 
Traumatic Hyperdynamic(early) 
Cardiogenic Hypodynamic(late) 
Intrinsic Neurogenic 
Compressive Hypoadrenal 
Table 1 : Classification of shock 
The scores used for blood pressure in SOFA are 
 Score 0 – No hypotension 
 Score 1- Mean arterial pressure <70 
 Score 2 – dopamine infusion </= 5 or requiring dobutamine 
 Score 3 – dopamine infusion >/= 5 or requiring nor epinephrine </=0.1 
 Score 4 – dopamine infusion > 15 or or requiring nor epinephrine 0.1 
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Figure 14 : Shock induced vicious cycle 
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MATERIALS AND METHODS 
100 patients admitted to the surgical unit in Coimbatore medical college 
hospital with suspected/confirmed sepsis  
STUDY DESIGN 
Prospective observational study 
STUDY GROUP 
Patients admitted to the surgical unit at Coimbatore medical college 
STUDY DURATION 
One year (September 2014- September 2015)  
INCLUSION CRITERIA  
All patients admitted to the surgical ward with suspected infection, 
satisfying Two or more criteria of systemic inflammation like 
 Heart rate ≥ 90 beats/min 
 Respiratory rate ≥20/min OR PaCo2<32mmHg 
 Temperature ≥38°C (100.4oF) or ≤36°C (96.8oF 
 WBC total count ≥12,000/mL or ≤4,000/mL  
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Patients which are included in the study are perforation peritonitis with 
Septicemia, Diabetic ulcer foot with gangrene, Necrotizing fascitis of limbs and 
abdomen, Burns, Mesenteric ischemia with bowel gangrene, Intestinal 
Obstruction, Carcinoma, Blunt injury abdomen with solid organ injury.  
EXCLUSION CRITERIA 
 All patients with age less than 12 years  
 All patients who will not give consent for study 
 Patients with HIV and chronic renal failure  
 Moribund and terminally ill patients with impending mortality within 
48-72 hours.                                                                                                                   
SAMPLE SIZE 
A total of 100 patients admitted to Coimbatore medical college surgical 
unit were studied 
CONSENT 
Informed consent was taken as per the standard procedures in the 
institution 
ETHICAL CLEARANCE 
Obtained from the ethical committee of the institution  
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PROCEDURE 
All patients with suspected/confirmed sepsis admitted in the surgical 
unit were included in the study. This included operated, non-operated and 
trauma patients (eg: perforation peritonitis, Diabetic ulcer foot with gangrene  
Necrotizing fascitis). Patients had to fulfill two or more criteria of systemic 
inflammation. The parameters involved in calculating the SOFA score were 
collected on a daily basis . The score  was calculated till discharge from ICU, 
mortality or day7 of admission to ward whichever was the earliest. The SOFA 
at admission was labelled T0 and at day 2 was labelled as T48(i.e. at 48 hours) 
and at day 4 was labelled as T96(i.e. at 96 hours)  . The difference calculated as 
Delta SOFA. The Maximum, Mean and total SOFA were also calculated and 
Compared with outcome of the patient. 
Blood Investigations were taken under aseptic conditions with adequate 
care and sent to the hospital 24 hours laboratory immediately. All the 
investigations were done in our hospital and no investigations or procedure 
done outside the hospital. Any experimental or so far unused materials or 
methods were not used on the patients. Serum bilirubin was calculated using an 
auto analyser using the method of malloy and evelyn.                                       
ABG was done using ion selective electrode in an ABG analyser. 
Platelet count was done using sysmex KX21.3 which is an automated cell 
count analyser, in clinical pathology lab. 
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STATISTICAL METHODS 
This is a prospective non interventional study. Data analysed using 
SPSS Software Version17. Descriptive statistics are reported using mean, 
median and SD for continuous variables, number and percentages for 
categorical variables. Logistic regression was used to find the predictors for 
mortality. Probability value less than 0.05 was considered statistically 
significant. 
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RESULTS 
SURVIVORS AND NON SURVIVORS 
Among the 100 patients involved in the study 53% survived and 47% 
succumbed to their illness. The minimum age of the person enrolled in the 
study was 17 and the maximum age was 85. 
SOFA SCORE ON ADMISSION 
SOFA score Survivors Non survivors Total 
6 – 7 5 1 6 
8 – 9 19 7 26 
10 – 11 13 4 17 
12 and above 16 35 51 
Total 53 47 100 
Table 2 : SOFA score on admission 
The minimum SOFA score of the patients admitted was 6. Hence the 
data column starts with values of 6 and above. This table shows that there is a 
sharp rise in non survivors at a SOFA score above 12. 
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AREA UNDER THE CURVE 
Test Result Variable(s):SOFA ADMISSION  
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.760 .048 .000 .665 .855 
The test result variable(s): SOFAADMISSION has at least one tie 
between the positive actual state group and the negative actual state group. 
Statistics may be biased. 
a. Under the nonparametric assumption  
b. Null hypothesis: true area = 0.5 
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ROC CURVE FOR ADMISSION SOFA 
 
 
 
 
 
 
 
 
 
Figure 15 : ROC Curve for Admission Sofa 
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BAR CHART 
NO. OF DEATHS 
 
Figure 16: Comparision between Admission SOFA and No. of Deaths 
The minimum admission SOFA score of patients in this study is 6. 
Among the 6 patients who had this score 1 patient expired. That is, the 
mortality rate is 16.7 %. Among the 51 patients who had an admission SOFA 
score of 12 and above 35 patients expired escalating the mortality rate to 
68.6%. 
 
 
 
1
7
4
35
0
10
20
30
40
SOFA 6 - 7 SOFA 8 -9 SOFA 10 - 11 SOFA 12 and 
above
Admission SOFA
Series 1
 
 
53 
 
SOFA AT 48 HOURS FOR NON SURVIVORS 
SOFA SCORE NO.OF NON SURVIVORS 
8 – 9 3 
10 - 11 4 
12 and above 40 
Table 3 : SOFA at 48 hours for non survivor 
At 48 hours the minimum SOFA score observed among the study 
population is 8. Hence the data column starts with 8 and above. 
AREA UNDER THE CURVE 
Test Result  
Variable(s): SOFA48Hr 
  
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.914 .028 .000 .859 .970 
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The test result variable(s): SOFA 48Hr has at least one tie between the 
positive actual state group and the negative actual state group. Statistics may be 
biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
ROC CURVE FOR SOFA AT 48 HOURS 
 
 
 
 
 
 
 
 
 
Figure 17: ROC Curve for SOFA at 48 Hours 
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BAR CHART 
NO. OF DEATHS 
 
 
Figure 18: Comparison between SOFA at 48 Hrs and No of Deaths 
  This picture shows that a SOFA score of 12 and above at 48 hours of 
admission shows an increase in the number of non survivors. The minimum 
SOFA score of the study population at 48 hours is 8. Among the 47 non 
survivors, 3 patients had these minimum score. Patients who had a score of 12 
and above were 40. 
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SOFA SCORE AT 96 HOURS FOR NON SURVIVORS 
 
SOFA SCORE NO. OF NON SURVIVORS 
8 – 9 3 
10 – 11 3 
12 and above 41 
Table 4 : SOFA Score at 96 hours for Non Survivors 
 
AREA UNDER THE CURVE 
Test Result Variable(s): SOFA 96HR 
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.937 .023 .000 .892 .982 
 
 
 
 
57 
 
 
ROC CURVE AT 96 HOURS 
 
 
 
 
 
 
 
 
 
Figure 19: ROC Curve at 96 Hours 
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BAR DIAGRAM 
NO OF DEATHS 
 
 
Figure 20: Comparison between SOFA at 96 Hrs and No of Deaths 
 
This chart depicts that survival rate is reduced when the SOFA score 
increases above 12, at 96 hours of admission. At 96 hours 41 out of the 47 
patients expired, had a score of 12 and above. 
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DELTA SOFA 
It is the difference between the subsequent SOFA scores. Δ SOFA 48 is 
the difference between admission score and the score at 48 hours. ΔSOFA 96 is 
the difference between the score at admission and 96 hours. 
SOFA SCORE 48 HOUR CHANGES 
The patient data is analysed as those who decreased, unchanged and 
increased from the initial score respectively, and the outcome is analysed. 
 
Δ SOFA 48 Survivors Non survivors 
Decreased 35 6 
Unchanged 8 9 
Increased 10 32 
 
Table 5 : SOFA score 48 hour changes 
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AREA UNDER THE CURVE 
Test Result Variable(s): SOFA 48 difference 
 
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.830 .041 .000 .749 .910 
SOFA 48 HOUR CHANGES: 
 
 
 
 
 
 
 
 
Figure 21 : ROC Curve for SOFA 48 Hrs changes 
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BAR CHART 
NO. OF DEATHS 
 
Figure 22: Comparison between SOFA 48 Hrs changes and no of deaths 
These data depicts that when the SOFA score is increased from 
admission to 48 hours, there is an increase in mortality. On contrary the 
mortality rate has decreased when the score falls. Among the 47 non survivors 
32 (68.08%) had an increase in their Δ48 scores. 
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SOFA SCORE 96 HOUR CHANGES 
The patient data is analysed as those who decreased, unchanged and 
increased from the initial score respectively, and the outcome is analysed. 
Δ SOFA 96 Survivors Non survivors 
Decreased 39 7 
Unchanged 7 2 
Increased 7 38 
Table 6 : SOFA score 96 hour changes 
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SOFA 96 HOUR CHANGES 
 
 
 
 
 
 
 
 
Figure 23 : ROC Curve of SOFA 96 Hrs Changes 
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BAR CHART 
NO. OF DEATHS 
 
Figure 24: Comparison between SOFA 96 Hrs change and no of deaths 
This chart depicts mortality rate is increased when the SOFA score is 
increased from admission to 96 hours. On contrary, the mortality rate has 
decreased when the score falls. Among the 47 non survivors 38 (80.85%) had 
an increase in their Δ 96 scores. 
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MEAN SOFA 
Mean SOFA calculates the average value of the prognostic score during 
the entire hospital stay of the patient. 
 
 
 
 
 
 
 
 
Figure 25: ROC Curve for Mean SOFA 
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AREA UNDER THE CURVE  
Test Result Variable(s): MEAN SOFA 
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.908 .029 .000 .851 .966 
 
COORDINATES OF THE CURVE 
Test Result Variable(s): MEAN SOFA 
 
Positive if Greater 
Than or Equal Toa Sensitivity 1 – Specificity 
4.3333 1.000 1.000 
5.6667 1.000 .962 
6.3333 1.000 .925 
7.0000 1.000 .755 
7.5000 1.000 .660 
7.8333 .979 .642 
8.1667 .957 .623 
8.5000 .936 .623 
8.8333 .936 .491 
9.1667 .936 .472 
9.5000 .915 .434 
10.0000 .915 .396 
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10.5000 .894 .321 
10.8333 .872 .226 
11.167 0.87 0.17 
11.5000 .830 .151 
11.8333 .809 .132 
12.1667 .766 .132 
12.5000 .723 .113 
12.8333 .660 .075 
13.1667 .660 .057 
13.5000 .617 .000 
13.8333 .574 .000 
14.1667 .532 .000 
14.5000 .489 .000 
14.8333 .404 .000 
15.1667 .383 .000 
15.5000 .319 .000 
16.1667 .277 .000 
16.8333 .213 .000 
17.1667 .191 .000 
17.5000 .149 .000 
18.0000 .106 .000 
18.5000 .064 .000 
20.0000 .021 .000 
22.3333 .000 .000 
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The test result variable(s): MEAN SOFA has at least one tie between the 
positive actual state group and the negative actual state group. 
The smallest cutoff value is the minimum observed test value minus 1, 
and the largest cutoff value is the maximum observed test value plus 1. All the 
other cutoff values are the averages of two consecutive ordered observed test 
values. These data shows that, a mean SOFA score of 11 and above is an 
excellent predictor of mortality, above which the number of non survivors  
increase. 
TOTAL SOFA 
It is the sum total of all the scores obtained from an individual patient 
during his hospital stay. It gives information about the severity of the illness 
since it gives the total worst score of all organs. 
AREA UNDER THE CURVE 
Test Result Variable(s):TOTALSOFA 
  
Area Std. Errora 
Asymptotic 
Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.908 .029 .000 .851 .966 
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COORDINATES OF THE CURVE 
Test Result Variable(s): TOTAL SOFA 
Positive if 
Greater Than 
or Equal Toa 
Sensitivity 1 – Specificity 
15.0000 1.000 1.000 
17.0000 1.000 .962 
19.0000 1.000 .925 
21.0000 1.000 .755 
22.5000 1.000 .660 
23.5000 .979 .642 
24.5000 .957 .623 
25.5000 .936 .623 
26.5000 .936 .491 
27.5000 .936 .472 
28.5000 .915 .434 
30.0000 .915 .396 
31.5000 .894 .321 
32.5000 .872 .226 
33.500 0.87 0.17 
34.5000 .830 .151 
35.5000 .809 .132 
36.5000 .766 .132 
37.5000 .723 .113 
38.5000 .660 .075 
39.5000 .660 .057 
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40.5000 .617 .000 
41.5000 .574 .000 
42.5000 .532 .000 
43.5000 .489 .000 
44.5000 .404 .000 
45.5000 .383 .000 
46.5000 .319 .000 
48.5000 .277 .000 
50.5000 .213 .000 
51.5000 .191 .000 
52.5000 .149 .000 
54.0000 .106 .000 
55.5000 .064 .000 
60.0000 .021 .000 
65.0000 .000 .000 
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The test result variable(s): TOTAL SOFA has at least one tie between 
the positive actual state group and the negative actual state group.                                  
The smallest cutoff value is the minimum observed test value minus 1, 
and the largest cutoff value is the maximum observed test value plus 1. All the 
other cutoff values are the averages of two consecutive ordered observed test 
values 
These data depict that a total SOFA score of 33 and above is an 
excellent predictor of mortality, above which the number of non survivors 
increase. 
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OUTCOME BASED ON SEX 
Sex Survivors Non survivors Total 
Male 33 36 69 
Female 20 11 31 
Total 53 47 100 
Table 7 : Outcome Based on Sex 
GRAPHIC REPRESENTATION 
 
Figure 26: Comparison between outcome and Sex 
Out of 69 male patients, 36 (52.2%) patients expired and out of 31 
female patients, 11(35.5%) patients expired. 
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OUTCOME FOR VENTILATOR SUPPORT 
 
Mechanical Ventilation 
status 
Survivors Non survivors 
Ventilated 8 33 
Non ventilated 45 14 
Table 8 : Outcome for ventilator support 
GRAPHIC REPRESENTATION 
 
Figure 27: Comparison between Outcome and Ventilator Support 
Among the 41 patients ventilated 33 (80.5%) expired and among the 59 
patients who did not require ventilator support 14 (23.7%) expired.  
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52
48
non-operated
operated
OPERATED AND NON-OPERATED CASES 
Status of operation Operated Non-operated Total 
Survivors 27 26 53 
Non-survivors 21 26 47 
Total 48 52 100 
Table 9 : Operated And Non-Operated Cases 
GRAPHIC REPRESENTATION 
 
 
 
 
 
 
Figure 28: Comparison between Operated and Non-Operated Cases 
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STATUS OF BODY FLUID CULTURES 
Positive 45 
Negative 55 
Table 10 : Status of Body Fluid Cultures 
 
GRAPHICAL REPRESENTATION 
                                
 
Figure 29 : Comparison between Status of Body Fluid Cultures 
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DISCUSSION 
Since the cost of health care is increasing day to day, assessment of a 
patient’s prognosis is vital during the course of treatment. Outcome prediction 
gains importance in this regard. So scoring systems have been used to predict 
this. SOFA scoring system, because of its simplicity and easy applicability, has 
been widely used in critical situation. This system has also been evaluated in 
many ICUs and found to be useful as a simple bedside tool.  
In our study sex of the patient did not play a significant role in 
influencing mortality. The morbidity and mortality is purely related to the 
underlying disease state. 
But, the need for mechanical ventilation clearly predicted mortality 
outcome, since the patients who were ventilated showed a higher mortality rate 
compared to those who did not require ventilator support, as evidenced by the 
statistically significant p value < 0.001. 
There is a significant increase in mortality rate when the SOFA score is 
above 12. There is a steep rise in the mortality curve at this value. Admission 
SOFA, 48 hours SOFA and 96 hours SOFA are all statistically significant with 
a p value < 0.001 
Delta SOFA which is the difference in values over a period of time is 
also statistically significant in our study. There is astrong evidence that, 
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patients whose delta SOFA values when increased from the previous value, 
there is a greater chance that the patient may succumb to his illness. 
Mean SOFA value also proved to be an independent predictor of 
mortality. A value of more than 11 showed a sharp rise in mortality. 
Total SOFA score is also statistically significant in predicting mortality, 
irrespective of the disease state. A total SOFA score of more than 33.5 is 
associated with increased mortality. 
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CONCLUSION 
 
 
 SOFA score is very useful in predicting mortality in critically ill 
patients, since there is a strong correlation between a rise in the score 
and mortality in all stages of admission. 
 Mechanically ventilated patients have a high risk of mortality compared 
to non ventilated patients. 
 The total SOFA and Mean sofa are better predictors of mortality.  
 Delta SOFA score is also a better predictor of mortality.  
 Early prediction of outcome in sepsis using SOFA score is useful to aid 
suitable modification of management strategies. 
 In our study, out of 51 patients whose admission SOFA score was very 
high (above 12), 16 patients were survived .This data depicts that, with 
early prediction of outcome using SOFA score and suitable therapeutic 
intervention, 16 critically ill patients were survived . 
 Same way out of 32 pts whose SOFA score on admission was low (less 
than 8), 8 pts died. This data depicts, even with low SOFA score on 
admission, few patients died, because so many other factors are also 
contributing to the death of critically ill patients.  
 So using SOFA scoring we can improve the overall prognosis and    
prevent the mortality to some extent.  
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ANNEXURE – I 
PROFORMA 
I. Basic Details: 
Name of the patient   :   
Age (in years)   :  
Sex     :      M / F     
Diagnosis    : 
Surgery                                       : 
II. History: 
i. Chief Complaints 
ii. Duration 
iii. History of present illness 
iv. Past History 
a. History of Pulmonary Disease 
b. History of Diabetes 
c. History of Heart Disease 
d. History of previous surgery 
v. Personal History 
a. History of smoking / alcoholism 
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III. General Examination: 
Pulse rate   : 
Blood Pressure  : 
Respiratory Rate  : 
SPO2(saturation)              : 
Temperature   :  
Glassgow coma score       : 
IV. Systemic Examination: 
i. Cardiovascular system 
ii. Respiratory system 
iii. Per abdomen examination 
iv. Central nervous system  
V. Blood investigations  
          I    Serum creatinine 
    II    Serum bilirubin 
         III   Platelet count 
VI.Follow up of patients 
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SOFA SCORE 
 
 0 1 2 3 4 
Respiration 
PaO2/FIO2 (mmHg) 
SaO2/FIO2 
>400 <400 
221–
301 
<300 
142–220 
<200 
67–141 
<100 
<67 
Coagulation 
Platelets 103/mm3 
>150 <150 <100 <50 <20 
Liver 
Bilirubin (mg/dL) 
<1.2 1.2–1.9 
 
1.9 2.0–5.9 6.0–11.9 >12.0 
Cardiovascular 
Hypotension 
No 
hypotension 
MAP 
<70 
Dopamine 
</=5 or 
Dobutamine 
(any) 
Dopamine 
>5 
or 
norepinep
hrine 
</=0.1 
Dopamine 
>15 or 
norepinep
hrine 
>0.1 
CNS 
Glasgow Coma score 
15 13-14 10-12 6-9 <6 
Renal 
Creatinine (mg/dL) 
or urine output(ML/dl) 
<1.2 1.2– 
1.9 
2.0–3.4 3.5–4.9 or 
<500 
>5.0 or 
<200 
MAP, mean arterial pressure; CNS, central nervous system; SaO2, 
peripheral arterial oxygen saturation. PaO2/FIO2 ratio was used preferentially. 
If not available, the SaO2/FIO2 ratio was used; vasoactive mediations 
administered for at least 1 hr (dopamine and norepinephrine ug/kg/min). 
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ANNEXURE - II 
INFORMED CONSENT 
DEPARTMENT OF GENERAL SURGERY 
Coimbatore Medical College, Coimbatore 
I have been invited to participate in the research project titled “use of 
SOFA(SEQUENTIAL  ORGAN  FAILURE  ASSESSMENT) scoring in 
assessing the incidence and severity of organ dysfunction and predicting the 
outcome in patients with sepsis in surgical unit” 
I understand, it will be answering a set of questionnaire, undergo 
physical examination, investigations and appropriate treatment. I also give 
consent to utilise my personal details for study purpose and can be contacted if 
necessary. I am aware that I have the right to withdraw at any time which will 
not affect my medical care. 
 
Name of the participant : 
Signature : 
Date : 
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ANNEXURE - III 
MASTER CHART 
S.NO Name AGE SEX DIAGNOSIS SOFA SCORE ON ADMISSION 
SOFA SCORE 
AT 48 HOURS 
SOFA SCORE 
AT 96 HOURS OUTCOME 
VENTILATOR 
SUPPORT OPERATED 
1 MURUGESAN 45 M PERFORATED PERITONITIS WITH SEPTICAEMIA 9 11 15 B YES YES 
2 VIJAYA 39 F PERFORATED PERITONITIS WITH SEPTICAEMIA 6 6 4 A NO YES 
3 LAKSHMI 40 F ELEPHANT ATTACK 8 10 13 B YES NO 
4 HAESHAN 35 M PERFORATIVE PERITONITIS 10 12 10 A NO YES 
5 KUMAR 65 M ILEAL PERFORATION 12 16 18 B NO YES 
6 YANISHA 19 F INTRACRANIAL SOLITARY LESION 10 12 12 B YES NO 
7 RAMAKRISHNAN 42 M DUODENAL PERFORATION 8 14 14 B YES YES 
8 BALAMANI 60 F SIGMOID VOLVULUS 12 10 10 A YES YES 
9 MANIKKAM 70 M CARCINOMA STOMACH 13 15 15 B YES YES 
10 SUMATHI 40 F 60% THERMAL BURNS 16 20 20 B NO NO 
11 SELVAM 57 M POSTAPPENDICECTOMY SEPTICEMIA 8 6 6 A NO YES 
12 GOVINDARAJ 71 M GASTRIC PERFORATION 8 4 4 A NO YES 
13 AMUDHA 40 F 30% BURNS WITH SEPTICEMIA 6 6 6 A YES NO 
14 JENCY 52 F CELLULITIS LT LOWER LIMB 8 10 10 A NO YES 
15 KANNAN 38 M BLUNT INJURY ABDOMEN 15 18 20 B NO YES 
16 SUBRAMANYAN 35 M STAB INJURY WITH LIVER LACERATION 8 6 6 A NO YES 
17 DEVRAJ 74 M SMALL BOWEL PERFORATION 15 18 18 B NO YES 
18 KARUPPASAMY 50 M RUPTURED LIVER ABSCESS 12 10 10 A NO YES 
19 KRISHNAN 63 M ACUTE INTESTINAL OBSTRUCTION 10 6 6 A NO YES 
20 VALLIYAMMAL 45 F 85% MIXED DEGREE BURNS 8 10 10 B YES NO 
21 SELVAM 70 M CAECAL PERFORATION WITH PERITONITIS 8 14 20 B YES YES 
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22 SANGEETHA 17 F 50% BURNS 12 16 16 B YES NO 
23 SIVAIKUMAR 28 M PERFORATIVE PERITONITIS 10 8 8 A NO YES 
24 MURUGESH 40 M ACUTE MESENTRIC ISCHEMIA 12 10 9 A NO YES 
25 KITTUSAMY 50 M SMALL BOWEL GANGRENE 8 6 6 A NO YES 
26 RAMASAMY 65 M ILEAL PERFORATION 12 10 10 B NO YES 
27 KANNARAJAN 65 M PERFORATIVE PERITONITIS 10 14 16 B NO YES 
28 NANJAMMAL 70 F 40% MIXED DEGREE BURNS 8 10 8 A NO NO 
29 MARUGATHAM 47 F CELLULITIS WITH GANGRENE LT UPPER LIMB 11 10 10 A NO NO 
30 SUBBATHAL 60 F DIABETIC ULCER FOOT 14 12 12 A NO NO 
31 BHUAMAN 59 M CARCINOMA RECTUM WITH SECONDARIES 16 18 19 B NO NO 
32 HYDHARALI 59 M DIABETES WITH MULTIORGAN FAILURE 15 20 20 B YES NO 
33 GOWRISANKAR 68 M GANGRENE FOOT 12 16 18 B YES NO 
34 CHANDRAN 41 M PERFORATIVE PERITONITIS 13 10 10 A NO YES 
35 KRISHNAVENI 50 F DIABETIC ULCER FOOT 15 12 12 A NO NO 
36 RANGASAMY 75 M CELLULITIS RT UPPER LIMB 11 10 10 A YES NO 
37 JAYARAM 60 M GANGRENE FOOT 11 15 15 B YES NO 
38 THNGAVEL 66 M CELLULITIS RT LOWER LIMB 8 8 8 A NO NO 
39 GOWRIYAMMAL 52 F CELLULITIS RT LOWER LIMB 8 10 8 A NO NO 
40 MOHAMMED 70 M CELLULITIS RT FOREARM 12 10 10 A NO NO 
41 IRUDHAYA RAJ 55 M DIABETIC FOOT LT LOWER LIMB 8 6 6 A NO YES 
42 BALU 37 M 30%BURNS 12 10 12 A YES NO 
43 MICHIYAMMAL 74 F PERFORATIVE PERITONITIS 12 13 13 B YES YES 
44 RAJASEKAR 35 M 30% BURNS 13 10 10 A YES NO 
45 VINOTH 54 M GANGRENE RT FOOT 10 12 14 B YES NO 
46 SARAVANAN 25 M PERFORATIVE PERITONITIS 10 8 8 A NO YES 
47 RAMESH 46 M CARCINOMA PANCREAS 15 15 16 B YES NO 
48 RAHUMAN 70 M BLUNT INJURY ABDOMEN 13 14 14 B NO YES 
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49 LAKSHMI 50 F OBSTRUCTED INCISIONAL HERNIA WITH FECAL FISTULA 13 14 16 B YES YES 
50 PRADEEP 50 M CELLULITIS RT LOWER LIMB 8 6 6 A NO NO 
51 GUNASEKAR 60 M 60% ELECTRICAL BURNS 12 16 16 B YES NO 
52 NOORJAHAN 53 F DIABETIC FOOT LT LOWER LIMB 8 7 7 A NO NO 
53 NATARAJAN 55 M NECROTIZING FASCITIS RT LOWER LIMB 14 16 17 B YES NO 
54 SANGUMUTHU 40 M SMALL BOWEL GANGRENE 10 9 8 A NO YES 
55 RAVISANKAR 52 M CELLULITIS LT LOWER LIMB 16 16 18 B YES NO 
56 GOVINDAN 66 M GANGRENE RT FOOT 13 12 12 B YES NO 
57 MANISHARMA 56 M PERFORATIVE PERITONITIS 14 15 16 B YES YES 
58 LAKSHMI 43 F DIABETIC FOOT LT LOWER LIMB 11 10 10 A NO NO 
59 SELVARAJ 46 M FOURNIERS GANGRENE 16 19 20 B YES NO 
60 BAKKIAMMAL 80 F DIABETIC FOOT WITH COPD 13 10 10 A NO NO 
61 INBARAASU 72 M HEPATOCELLULAR CARCINOMA 8 8 9 B NO NO 
62 ELANGOVAN 46 M BLUNT INJURY ABDOMEN 8 6 6 A NO YES 
63 PALANIYAMMAL 75 F CELLULITIS BOTH LOWER LIMBS 10 8 8 A YES NO 
64 ANBUMANI 61 M SNAKE BITE CELLULITIS 8 10 10 A NO YES 
65 SIVASENBAGAM 40 F GANGRENE RT FOOT 12 12 10 B NO NO 
66 SUNDAR 45 M 80% BURNS 16 12 12 B YES NO 
67 HARIHARAN 35 M 30% BURNS 8 7 7 A NO NO 
68 BATHRAN 60 M DIABETIC ULCER LT LOWER LIMB 8 6 6 A NO NO 
69 PALANISAMY 65 M DIABETIC GANGRENE LT LOWER LIMB 12 16 16 B YES NO 
70 MARIYAPPAN 66 M CELLULITIS LT LOWER LIMB 7 10 9 A NO YES 
71 LAKSHMI 45 F NECROTIZING FASCITIS RT LOWER LIMB 16 18 18 B YES NO 
72 SATHISH 30 M STRANGULATED INGUINAL HERNIA 20 22 22 B YES YES 
73 KANDHASAMY 60 M INTESTINAL OBSTRUCTION WTH BOWEL GANGRENE 10 6 6 A NO YES 
74 SULOCHANA 63 F DIABETIC ULCER RT FOOT 16 12 12 A NO NO 
75 NAGARATHINAM 60 F RT BREAST ABSCESS 20 18 18 B YES YES 
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76 AYYASAMY 49 M SMALL BOWEL GANGRENE 16 18 18 B N0 YES 
77 SUSEELA 45 F DIABETIC KETOACIDOSIS WITH CELLULITIS 6 6 6 A NO NO 
78 UMADEVI 60 F CELLULITIS BOTH LOWER LIMBS 12 14 14 A NO NO 
79 RAMASAMY 60 M ISCHEMIC BOWEL DISEASE 18 16 16 B YES NO 
80 PANDIYAN 40 M PNEUMOTHORAX 10 8 8 A NO YES 
81 ABDUL RAHAMAN 53 M CARCINOMA STOMACH 12 14 16 B YES NO 
82 ANTONY MURTHY 75 M PERFORATIVE PERITONITIS 13 12 12 A NO YES 
83 MANIKANDAN 25 M POLYTRAUMA-POST SPLEENECTOMY 13 16 18 B NO YES 
84 MANILLAVARASAN 43 M ILEOCOLIC INTUSUSSEPTION 12 12 8 A YES YES 
85 MURUGESAN 45 M GASTROJEJUNOSTOMY WITH STOMAL PERFORATION 8 8 6 A NO YES 
86 SUBRAMANI 65 M CARCINOMA RECTUM 14 14 16 B YES NO 
87 RAMACHANDRAN 47 M ILEAL PERFORATION 8 8 8 B YES YES 
88 RAJAN 60 M MESENTERIC VASCULAR ISCHAEMIA 13 13 12 B NO YES 
89 SELVARAJ 59 M HEPATOCELLULAR CARCINOMA 6 8 9 B YES NO 
90 THANGAMMAL 58 F NON-HEALING ULCER LT FOOT 12 12 13 B YES NO 
91 THIRUMOORTHY 50 M BOWEL ISCHAEMIA 14 12 12 A NO NO 
92 PRIYADHARSHINI 23 F SNAKE BITE CELLULITIS 8 6 6 A NO NO 
93 MUNUSAMY 63 M PERFORATIVE PERITONITIS 10 10 9 A NO YES 
94 RAMACHANDRAN 35 M RUPTURED LIVER ABSCESS 13 12 13 B YES YES 
95 PHILOMINA 65 F DIABETIC FOOT RT 9 10 10 A NO NO 
96 SAROJA 70 F DIABETIC FOOT RT 14 13 13 A YES NO 
97 ARUNKUMR 20 M PERFORATIVE PERITONITIS 10 12 13 A NO YES 
98 GOPAL 63 M CARCINOMA RECTOSIGMOID 16 16 18 B NO YES 
99 LAKSHMI 45 F CELLULITIS LT LOWER LIMB 6 7 7 A NO NO 
100 KUMAR 38 M ILEAL PERFORATION 8 8 7 A NO YES 
A – SURVIVORS, B – NON SURVIVORS 
